Peripheral Arterial Disease Clinical Trials in Chicago, Illinois

6 studies are recruiting for peripheral arterial disease in Chicago, Illinois right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. SELUTION4BTK Trial

   This study aims to demonstrate superior efficacy and equivalent safety of the SELUTION SLR™ DEB 014 compared to plain (uncoated) balloon angioplasty in the treatment of peripheral arterial disease (PAD) in the BTK arteries in CLTI patients.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Rush University Medical Center, Chicago, Illinois

   Locations

   48 in total

   Run by

   M.A. Med Alliance S.A.

   See if you can join NCT05055297 on ClinicalTrials.gov

2. PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia

   A prospective, single-arm, multi-center study designed to gather additional information on the LimFlow System.

   Stage

   Not phased

   Ages

   18 to 95

   Site

   Rush University Medical Center, Chicago, Illinois

   Locations

   30 in total

   Run by

   LimFlow, Inc.

   See if you can join NCT05313165 on ClinicalTrials.gov

3. SMART Exercise for PAD

   Supervised exercise therapy (SET), consisting of treadmill exercise conducted three times weekly at a center while supervised by healthcare personnel, is first line therapy for people disabled by lower extremity peripheral artery disease (PAD). However, travelling three times/week to a center for S…

   Stage

   Phase 3

   Ages

   50 and older

   Site

   Northwestern University Feinberg School of Medicine, Chicago, Illinois

   Locations

   3 in total

   Run by

   Northwestern University

   See if you can join NCT06032065 on ClinicalTrials.gov

4. Fisetin to Reduce Senescence and Mobility Impairment in PAD

   The investigators propose a pilot randomized trial to gather preliminary data to test the hypothesis that Fisetin will reduce abundance of senescent cells in blood, skeletal muscle, and both subcutaneous and inter muscular adipose tissue and improve 6-minute walk distance in 34 people with peripher…

   Stage

   Phase 2

   Ages

   50 and older

   Site

   Northwestern University Feinberg School of Medicine, Chicago, Illinois

   Run by

   Northwestern University

   See if you can join NCT06399809 on ClinicalTrials.gov

5. Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk

   The Low dose ColchicinE in pAtients with peripheral Artery DiseasE to address residual vascular Risk (LEADER-PAD) trial will evaluate if anti-inflammatory therapy with colchicine will reduce vascular events in patients with symptomatic peripheral artery disease.

   Stage

   Phase 3

   Ages

   18 and older

   Site

   University of Chicago Medical Center, Chicago, Illinois

   Locations

   70 in total

   Run by

   Population Health Research Institute

   See if you can join NCT04774159 on ClinicalTrials.gov

6. Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes

   XLPAD is an observational study designed to evaluate the effectiveness and use of stent and non-stent based therapies among PAD patients. The study will create a registry that will include entry of procedural and clinical follow-up information into an online data collection software, REDCAP.Data av…

   Stage

   Not phased

   Ages

   Any age

   Site

   Loyola University Medical Center, Chicago, Illinois

   Locations

   24 in total

   Run by

   Baylor Research Institute

   See if you can join NCT01904851 on ClinicalTrials.gov